Literature DB >> 14018083

Inactive prednisone tablets U.S.P. XVI.

F A CAMPAGNA, G CURETON, R A MIRIGIAN, E NELSON.   

Abstract

Entities:  

Keywords:  PREDNISONE

Mesh：

Substances：

Year:  1963        PMID： 14018083     DOI： 10.1002/jps.2600520626

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN： 0022-3549            Impact factor:   3.534


× No keyword cloud information.
  7 in total

1.  Serum concentrations and bioavailability of rifampicin and isoniazid in combination.

Authors:  J C Garnham; T Taylor; P Turner; L F Chasseaud
Journal:  Br J Clin Pharmacol       Date:  1976-10       Impact factor: 4.335

2.  Comparative bioavailability: eight commercial prednisone tablets.

Authors:  T J Sullivan; M R Hallmark; E Sakmar; D J Weidler; R H Earhart; J G Wagner
Journal:  J Pharmacokinet Biopharm       Date:  1976-04

3.  Pharmacokinetics and relative bioavailability of heptabarbital and heptabarbital sodium after oral administration to man.

Authors:  D D Breimer; A G de Boer
Journal:  Eur J Clin Pharmacol       Date:  1975-12-19       Impact factor: 2.953

Review 4.  Some aspects of the influence of formulation on the bioavailability of drugs from solid dosage forms.

Authors:  O I Corrigan; R F Timoney
Journal:  Ir J Med Sci       Date:  1974-07       Impact factor: 1.568

Review 5.  Pharmacokinetics and bioavailability of prednisone and prednisolone in healthy volunteers and patients: a review.

Authors:  J G Gambertoglio; W J Amend; L Z Benet
Journal:  J Pharmacokinet Biopharm       Date:  1980-02

6.  The biopharmaceutical properties of solid dosage forms. I. An evaluation of 23 brands of phenylbutazone tablets.

Authors:  R O Searl; M Pernarowski
Journal:  Can Med Assoc J       Date:  1967-06-10       Impact factor: 8.262

7.  Effect of food on the absorption and pharmacokinetics of prednisolone from enteric-coated tablets.

Authors:  S M Al-Habet; H J Rogers
Journal:  Eur J Clin Pharmacol       Date:  1989       Impact factor: 2.953
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.